HomePER • ASX
add
Percheron Therapeutics Ltd
Previous close
$0.0070
Day range
$0.0070 - $0.0070
Year range
$0.0060 - $0.013
Market cap
5.33M AUD
Avg Volume
655.17K
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 44.20K | -41.75% |
Operating expense | 1.53M | -64.26% |
Net income | -1.55M | 63.62% |
Net profit margin | -3.51K | 37.54% |
Earnings per share | — | — |
EBITDA | -1.54M | 63.76% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.46M | -74.37% |
Total assets | 7.90M | -55.91% |
Total liabilities | 763.70K | -70.96% |
Total equity | 7.14M | — |
Shares outstanding | 1.09B | — |
Price to book | 0.70 | — |
Return on assets | -48.96% | — |
Return on capital | -54.12% | — |
Cash Flow
Net change in cash
| (AUD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.55M | 63.62% |
Cash from operations | -1.30M | 69.27% |
Cash from investing | -1.54M | -42,489.95% |
Cash from financing | -12.67K | -100.18% |
Net change in cash | -2.86M | -203.44% |
Free cash flow | -2.38M | 2.29% |
About
CEO
Founded
2000
Headquarters
Website
Employees
8
